Afya (NASDAQ:AFYA) VP Sells $543,060.00 in Stock

Afya Limited (NASDAQ:AFYA) VP Lelio De Souza Junior sold 36,204 shares of the stock in a transaction dated Wednesday, July 1st. The shares were sold at an average price of $15.00, for a total value of $543,060.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Lelio De Souza Junior also recently made the following trade(s):

• On Friday, June 26th, Lelio De Souza Junior sold 41,541 shares of Afya stock. The stock was sold at an average price of $15.00, for a total value of $623,115.00.
• On Thursday, April 9th, Lelio De Souza Junior sold 16,279 shares of Afya stock. The shares were sold at an average price of $14.53, for a total value of $236,533.87.
• On Tuesday, April 7th, Lelio De Souza Junior sold 26,753 shares of Afya stock. The shares were sold at an average price of $14.95, for a total value of $399,957.35.

Afya Stock Up 0.3%

AFYA stock opened at $14.82 on Thursday. The company has a current ratio of 1.78, a quick ratio of 1.78 and a debt-to-equity ratio of 0.42. The firm has a 50 day simple moving average of $14.32 and a 200-day simple moving average of $14.55. The company has a market capitalization of $1.39 billion, a P/E ratio of 9.69, a PEG ratio of 1.47 and a beta of 0.32. Afya Limited has a twelve month low of $13.00 and a twelve month high of $16.57.

Hedge Funds Weigh In On Afya

A number of large investors have recently bought and sold shares of AFYA. Doma Perpetual Capital Management LLC boosted its stake in Afya by 50.6% in the third quarter. Doma Perpetual Capital Management LLC now owns 891,639 shares of the company’s stock valued at $13,910,000 after acquiring an additional 299,419 shares during the period. Swedbank AB raised its position in shares of Afya by 170.3% during the 4th quarter. Swedbank AB now owns 189,200 shares of the company’s stock worth $2,916,000 after purchasing an additional 119,200 shares during the period. Jump Financial LLC acquired a new stake in shares of Afya during the 2nd quarter worth approximately $731,000. Qube Research & Technologies Ltd bought a new stake in shares of Afya in the 3rd quarter worth approximately $610,000. Finally, Pictet Asset Management Holding SA acquired a new position in Afya during the 4th quarter valued at approximately $508,000. Institutional investors own 88.02% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on AFYA shares. Bank of America reaffirmed a “neutral” rating on shares of Afya in a research report on Thursday, June 11th. Wall Street Zen cut Afya from a “strong-buy” rating to a “buy” rating in a research note on Saturday, May 2nd. Weiss Ratings reiterated a “hold (c)” rating on shares of Afya in a research report on Monday, April 20th. JPMorgan Chase & Co. lowered their price target on Afya from $21.50 to $21.00 and set a “neutral” rating for the company in a report on Monday, June 22nd. Finally, Zacks Research lowered Afya from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, May 6th. One equities research analyst has rated the stock with a Buy rating and seven have issued a Hold rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $17.10.

About Afya

Afya Ltd. operates as a leading provider of medical education and training services in Brazil. The company offers a comprehensive suite of educational programs that span undergraduate medical degrees, residency exam preparation, continuing medical education (CME) and digital learning platforms. Through a network of partner institutions and its own campus operations, Afya supports students at every stage of the medical training continuum, from enrollment in medical schools to ongoing professional development for practicing physicians.

At the core of Afya’s offerings is its undergraduate medical program, delivered through a combination of in-person courses at affiliated campuses and fully digital curricula.